Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
L-tartaric acid is a naturally occurring organic acid found in many plants, especially grapes and tamarinds. It is a white crystalline diprotic alpha-hydroxy-carboxylic acid and a dihydroxyl derivative of succinic acid. L-tartaric acid is widely used as an excipient in pharmaceutical manufacturing to improve the taste of oral medications and to generate carbon dioxide when combined with sodium bicarbonate for effervescent formulations[1][4]. Pharmacologically, it has demonstrated antihypertensive and vasorelaxant effects in animal studies through activation of the endothelial nitric oxide synthase/nitric oxide/cyclic guanosine monophosphate (eNOS/NO/cGMP) pathway[5]. It also acts as an antioxidant but can be toxic at high doses due to its inhibition of malic acid production[8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on L-tartaric acid.